Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Explore the debate surrounding animal testing as new methods may jeopardise patient safety if not properly validated.

Please provide your email address to receive an email when new articles are posted on . The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and ...

Johns Hopkins’ Thomas Hartung discusses how drug discovery and development will change under evolving regulatory policies ...

Add Yahoo as a preferred source to see more of our stories on Google. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival time after ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...

Step inside an abandoned animal testing facility dating back to the 1960s and uncover what remains behind its sealed doors. This urban exploration reveals old laboratory equipment, research rooms, and ...

I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival time after ...